Ameritas Investment Partners, Inc. - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 49 filers reported holding TALARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,096
+43.5%
1,6470.0%0.00%
Q4 2022$2,158
-46.0%
1,6470.0%0.00%
Q3 2022$4,000
-42.9%
1,6470.0%0.00%
Q2 2022$7,000
-56.2%
1,6470.0%0.00%
-100.0%
Q1 2022$16,000
-36.0%
1,6470.0%0.00%0.0%
Q4 2021$25,000
+177.8%
1,647
+136.0%
0.00%
Q3 2021$9,000
-10.0%
6980.0%0.00%
Q2 2021$10,0006980.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$8,240,62310.94%
BML Capital Management, LLC 2,000,000$5,620,0005.16%
Nantahala Capital Management 2,953,129$8,298,2920.71%
GREAT POINT PARTNERS LLC 1,000,000$2,810,0000.51%
Acuitas Investments, LLC 194,547$546,6770.32%
Affinity Asset Advisors, LLC 400,000$1,124,0000.32%
RA Capital Management 2,403,238$6,753,0990.13%
Artal Group S.A. 914,262$2,5690.11%
Blackstone Inc. 8,089,315$22,730,9750.10%
QVT Financial LP 589,314$1,655,9720.09%
View complete list of TALARIS THERAPEUTICS INC shareholders